163 related articles for article (PubMed ID: 24349253)
1. Computer-based image studies on tumor nests mathematical features of breast cancer and their clinical prognostic value.
Wang LW; Qu AP; Yuan JP; Chen C; Sun SR; Hu MB; Liu J; Li Y
PLoS One; 2013; 8(12):e82314. PubMed ID: 24349253
[TBL] [Abstract][Full Text] [Related]
2. The significance of tumour microarchitectural features in breast cancer prognosis: a digital image analysis.
Roxanis I; Colling R; Kartsonaki C; Green AR; Rakha EA
Breast Cancer Res; 2018 Feb; 20(1):11. PubMed ID: 29402299
[TBL] [Abstract][Full Text] [Related]
3.
Groheux D; Martineau A; Teixeira L; Espié M; de Cremoux P; Bertheau P; Merlet P; Lemarignier C
Breast Cancer Res; 2017 Jan; 19(1):3. PubMed ID: 28057031
[TBL] [Abstract][Full Text] [Related]
4. New breast cancer prognostic factors identified by computer-aided image analysis of HE stained histopathology images.
Chen JM; Qu AP; Wang LW; Yuan JP; Yang F; Xiang QM; Maskey N; Yang GF; Liu J; Li Y
Sci Rep; 2015 May; 5():10690. PubMed ID: 26022540
[TBL] [Abstract][Full Text] [Related]
5. p53 overexpression is a predictor of local recurrence after treatment for both in situ and invasive ductal carcinoma of the breast.
de Roos MA; de Bock GH; de Vries J; van der Vegt B; Wesseling J
J Surg Res; 2007 Jun; 140(1):109-14. PubMed ID: 17291532
[TBL] [Abstract][Full Text] [Related]
6. Immunohistochemistry profiles of breast ductal carcinoma: factor analysis of digital image analysis data.
Laurinavicius A; Laurinaviciene A; Ostapenko V; Dasevicius D; Jarmalaite S; Lazutka J
Diagn Pathol; 2012 Mar; 7():27. PubMed ID: 22424533
[TBL] [Abstract][Full Text] [Related]
7. Can Occult Invasive Disease in Ductal Carcinoma In Situ Be Predicted Using Computer-extracted Mammographic Features?
Shi B; Grimm LJ; Mazurowski MA; Baker JA; Marks JR; King LM; Maley CC; Hwang ES; Lo JY
Acad Radiol; 2017 Sep; 24(9):1139-1147. PubMed ID: 28506510
[TBL] [Abstract][Full Text] [Related]
8. Prognostic value of phosphorylated HER2 in HER2-positive breast cancer patients treated with adjuvant trastuzumab.
Kurebayashi J; Kanomata N; Yamashita T; Shimo T; Mizutoh A; Moriya T; Sonoo H
Breast Cancer; 2015 May; 22(3):292-9. PubMed ID: 23749689
[TBL] [Abstract][Full Text] [Related]
9. Comparison of the prognostic value of genomic grade index, Ki67 expression and mitotic activity index in early node-positive breast cancer patients.
Bertucci F; Finetti P; Roche H; Le Doussal JM; Marisa L; Martin AL; Lacroix-Triki M; Blanc-Fournier C; Jacquemier J; Peyro-Saint-Paul H; Viens P; Sotiriou C; Birnbaum D; Penault-Llorca F
Ann Oncol; 2013 Mar; 24(3):625-32. PubMed ID: 23117074
[TBL] [Abstract][Full Text] [Related]
10. Increased expression of senescence markers p14(ARF) and p16(INK4a) in breast cancer is associated with an increased risk of disease recurrence and poor survival outcome.
Pare R; Shin JS; Lee CS
Histopathology; 2016 Sep; 69(3):479-91. PubMed ID: 26843058
[TBL] [Abstract][Full Text] [Related]
11. Pretreatment neutrophil-to-lymphocyte ratio is correlated with response to neoadjuvant chemotherapy as an independent prognostic indicator in breast cancer patients: a retrospective study.
Chen Y; Chen K; Xiao X; Nie Y; Qu S; Gong C; Su F; Song E
BMC Cancer; 2016 May; 16():320. PubMed ID: 27198767
[TBL] [Abstract][Full Text] [Related]
12. Ductal carcinoma in situ of the breast (DCIS) with heterogeneity of nuclear grade: prognostic effects of quantitative nuclear assessment.
Chapman JA; Miller NA; Lickley HL; Qian J; Christens-Barry WA; Fu Y; Yuan Y; Axelrod DE
BMC Cancer; 2007 Sep; 7():174. PubMed ID: 17845726
[TBL] [Abstract][Full Text] [Related]
13. Progranulin (GP88) tumor tissue expression is associated with increased risk of recurrence in breast cancer patients diagnosed with estrogen receptor positive invasive ductal carcinoma.
Serrero G; Hawkins DM; Yue B; Ioffe O; Bejarano P; Phillips JT; Head JF; Elliott RL; Tkaczuk KR; Godwin AK; Weaver J; Kim WE
Breast Cancer Res; 2012 Feb; 14(1):R26. PubMed ID: 22316048
[TBL] [Abstract][Full Text] [Related]
14. Quantitative ultrasound as a predictor of node metastases and prognosis in patients with breast cancer.
Hashimoto H; Suzuki M; Oshida M; Nagashima T; Yagata H; Shishikura T; Imanaka N; Nakajima N
Breast Cancer; 2000; 7(3):241-6. PubMed ID: 11029805
[TBL] [Abstract][Full Text] [Related]
15. Relationship between parameters from virtual touch tissue quantification (VTQ) imaging with clinicopathologic prognostic factors in women with invasive ductal breast cancer.
Xie J; Wu R; Xu HX; Yao MH; Xu G
Int J Clin Exp Pathol; 2014; 7(10):6644-52. PubMed ID: 25400743
[TBL] [Abstract][Full Text] [Related]
16. The relationship between lymphocyte subsets and clinico-pathological determinants of survival in patients with primary operable invasive ductal breast cancer.
Mohammed ZM; Going JJ; Edwards J; Elsberger B; McMillan DC
Br J Cancer; 2013 Sep; 109(6):1676-84. PubMed ID: 23982600
[TBL] [Abstract][Full Text] [Related]
17. Tumor thickness and histological features as predictors of invasive foci within preoperatively diagnosed ductal carcinoma in situ.
Mori K; Takeda M; Kodama Y; Kiyokawa H; Yasojima H; Mizutani M; Otani Y; Morikawa N; Masuda N; Mano M
Hum Pathol; 2017 Jun; 64():145-155. PubMed ID: 28434924
[TBL] [Abstract][Full Text] [Related]
18. Grading invasive ductal carcinoma of the breast: advantages of using automated proliferation index instead of mitotic count.
Tawfik O; Kimler BF; Davis M; Stasik C; Lai SM; Mayo MS; Fan F; Donahue JK; Damjanov I; Thomas P; Connor C; Jewell WR; Smith H; Fabian CJ
Virchows Arch; 2007 Jun; 450(6):627-36. PubMed ID: 17458558
[TBL] [Abstract][Full Text] [Related]
19. Preoperative tumor texture analysis on MRI predicts high-risk disease and reduced survival in endometrial cancer.
Ytre-Hauge S; Dybvik JA; Lundervold A; Salvesen ØO; Krakstad C; Fasmer KE; Werner HM; Ganeshan B; Høivik E; Bjørge L; Trovik J; Haldorsen IS
J Magn Reson Imaging; 2018 Dec; 48(6):1637-1647. PubMed ID: 30102441
[TBL] [Abstract][Full Text] [Related]
20. Histological factors for accurately predicting first locoregional recurrence of invasive ductal carcinoma of the breast.
Hasebe T; Iwasaki M; Hojo T; Shibata T; Kinoshita T; Tsuda H
Cancer Sci; 2013 Sep; 104(9):1252-61. PubMed ID: 23758085
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
